These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9696398)

  • 1. The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer.
    Goodson WH; Moore DH; Ljung BM; Chew K; Florendo C; Mayall B; Smith HS; Waldman FM
    Breast Cancer Res Treat; 1998 May; 49(2):155-64. PubMed ID: 9696398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
    Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM
    Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
    Thor AD; Liu S; Moore DH; Edgerton SM
    J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
    Onda K; Davis RL; Wilson CB; Hoshino T
    Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor labeling indices of primary breast cancers and their regional lymph node metastases.
    Goodson WH; Ljung BM; Moore DH; Mayall B; Waldman FM; Chew K; Benz CC; Smith HS
    Cancer; 1993 Jun; 71(12):3914-9. PubMed ID: 8508357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
    Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
    J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
    Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
    Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
    Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
    Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
    Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
    Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J
    Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.
    Sasaki K; Matsumura K; Murakami T; Tsuji T
    Oncology; 1992; 49(2):147-53. PubMed ID: 1574251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.
    Sasaki K; Matsumura K; Tsuji T; Shinozaki F; Takahashi M
    Cancer; 1988 Sep; 62(5):989-93. PubMed ID: 3409179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
    Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
    Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurement of breast cancer growth rate.
    Goodson WH; Ljung BM; Waldman F; Mayall B; Chew K; Moore DH; Smith H; Goldman ES; Benz C
    Arch Surg; 1991 Oct; 126(10):1220-3; discussion 1223-4. PubMed ID: 1929822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells.
    Bardenstein DS; Char DH; Kaleta-Michaels S; Kroll SM
    Curr Eye Res; 1991 May; 10(5):479-84. PubMed ID: 1889233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade.
    Weidner N; Moore DH; Ljung BM; Waldman FM; Goodson WH; Mayall B; Chew K; Smith HS
    Am J Surg Pathol; 1993 Oct; 17(10):987-94. PubMed ID: 8372950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
    Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
    J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.